0000200406-23-000109.txt : 20231130 0000200406-23-000109.hdr.sgml : 20231130 20231130163038 ACCESSION NUMBER: 0000200406-23-000109 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20231130 ITEM INFORMATION: Other Events FILED AS OF DATE: 20231130 DATE AS OF CHANGE: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 231456242 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20231130.htm 8-K jnj-20231130
0000200406false00002004062023-11-302023-11-300000200406us-gaap:CommonStockMember2023-11-302023-11-300000200406jnj:A0.650NotesDue2024Member2023-11-302023-11-300000200406jnj:A5.50NotesDue2024Member2023-11-302023-11-300000200406jnj:A1.150NotesDue2028Member2023-11-302023-11-300000200406jnj:A1.650NotesDue2035Member2023-11-302023-11-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): 
November 30, 2023

Johnson & Johnson
 (Exact name of registrant as specified in its charter)
  
New Jersey1-321522-1024240
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)

One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933 
(Address of Principal Executive Offices)
 (Zip Code) 
Registrant's telephone number, including area code:
732-524-0400
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
☐             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
               CFR 240.14d-2(b)) 
☐             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
               CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Par Value $1.00JNJNew York Stock Exchange
0.650% Notes Due May 2024JNJ24CNew York Stock Exchange
5.50% Notes Due November 2024JNJ24BPNew York Stock Exchange
1.150% Notes Due November 2028JNJ28New York Stock Exchange
1.650% Notes Due May 2035JNJ35New York Stock Exchange



Item 8.01    Other Events

Today, the Company announced its acquisition of Laminar, Inc. As a result of the acquisition, Johnson & Johnson will be adjusting its expected Adjusted Fiscal Year 2023 EPS. The asset acquisition will require an in-process research and development charge which will reduce operational and reported Adjusted EPS by approximately $0.17 from guidance previously issued. The new expected operational and reported Adjusted EPS ranges are now $9.85 to $9.91 and $9.90 to $9.96, respectively. Additionally, the asset acquisition is expected to have an approximate negative $0.15 EPS impact in fiscal year 2024.

The Company’s press release announcing the acquisition is attached to this Report as Exhibit 99.1.

Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements regarding the acquisition of Laminar, Inc. and its expected effect on our financial results. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our current expectations and projections. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 1, 2023, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Any forward-looking statement made in this release speaks only as of the date of this release. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.

Non-GAAP Financial Measures

This Current Report on Form 8-K includes Adjusted EPS, which represents a non-GAAP financial measure. The Company believes that providing this non-GAAP financial measure enhances the Company’s and investors’ understanding of our financial performance. Non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. The Company’s definitions of its non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. The most directly comparable GAAP measure to Adjusted EPS is earnings per share, or EPS. The Company is not providing a reconciliation of Adjusted EPS to EPS, however, because Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis as the Company is unable to predict with reasonable certainty the ultimate outcome of adjusted items, such as legal proceedings, unusual gains and losses, acquisition-related expenses, and purchase accounting fair value adjustments without unreasonable effort. These items are uncertain, depend on various factors, and could be material to Johnson & Johnson's results computed in accordance with GAAP.

Item 9.01    Financial Statements and Exhibits


(d)     Exhibits. 
 
Exhibit No.
 		Description of Exhibit
 
99.1
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 Johnson & Johnson 
   (Registrant)
 
 
 		 
Date: November 30, 2023By:/s/ Marc Larkins 
  Marc Larkins
Corporate Secretary		 

 EX-99.1 2 exhibit991-pressrelease.htm EX-99.1 Document
medtech.jpg
Exhibit 99.1

For immediate release
image_0a.jpg
Johnson & Johnson MedTech Acquires Laminar, Inc.
Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
Strengthens position in high-growth MedTech segments
NEW BRUNSWICK, N.J. – November 30, 2023 – Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and regulatory milestone payments in 2024 and beyond. Laminar joins Johnson & Johnson MedTech as part of Biosense Webster, Inc. – a global leader in cardiac arrhythmia treatment.
Today, approximately 38 million patients around the world are living with AFib, which causes them to be more than five times as likely to have a stroke3. The LAA is a small pouch in the left atrium of the heart and can be a source of clots that can enter the blood stream, potentially causing a stroke. The LAA is a major contributor to thromboembolic stroke in patients with non-valvular atrial fibrillation. 

Unlike current commercial catheter-based procedure devices that use plugs to occlude the LAA, Laminar's novel approach uses rotational motion to eliminate the LAA. Laminar recently received FDA approval for the U.S. pivotal study, which will begin enrollment in early 2024.

LAA closure is an FDA-approved therapy for reducing the risk of thromboembolism in atrial fibrillation patients who are recommended for chronic oral anticoagulation therapy but have an appropriate rationale to seek a non-pharmacologic alternative to chronic oral anticoagulants4. This is particularly important for the nearly 40% of AFib patients who cannot tolerate long-term blood thinners5,6.
“For the millions of people living with AFib, stroke risk is a major concern. The team at Laminar is driven by our vision to develop and deliver an innovative solution to help patients live without the fear of stroke, or the need for long-term use of blood thinners,” said Randy Lashinski, President & CEO, Laminar. “We are looking forward to advancing this vision as part of Johnson & Johnson MedTech.”
“We are excited to welcome Laminar to Johnson & Johnson MedTech,” said Jasmina Brooks, President, Biosense Webster. “Laminar’s innovative approach will provide Biosense Webster the
1 Comprising the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s MedTech segment.
2 The acquisition was made jointly by Johnson & Johnson and Ethicon, Inc.
3 Holmes, DR. et al. Seminars in Neurology, 2010; 30:528-536.
4 Wolfe Research, company reports, Society for Cardiovascular Angiography Intervention (SCAI), Europace, JAAC, and ScienceDirect
5 Marzecet al. JACC 2017: 69(20): 2478484
6 Baker, C.L., Dhamane, A.D., Mardekian, J. et al. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States. Adv Ther 36, 162–174 (2019). https://doi.org/10.1007/s12325-018-0840-8


medtech.jpg
Exhibit 99.1

opportunity to expand our portfolio in this high growth market, complement our electrophysiology and Intracardiac Echo strengths, and deepen our presence with interventional cardiologists and electrophysiologists. Fueled by the global scale and commercial and clinical strength of Biosense Webster, we are excited to explore the possibilities ahead to reach even more patients with critical unmet need.”
As a result of the acquisition of Laminar, Inc., Johnson & Johnson will be adjusting its expected Adjusted EPS for fiscal year 2023. The asset acquisition will require an in-process research and development charge which will reduce operational and reported Adjusted EPS by approximately $0.17 from guidance previously issued. The new expected operational and reported Adjusted EPS ranges for 2023 are now $9.85 to $9.91 and $9.90 to $9.96, respectively. Additionally, the asset acquisition is expected to have an approximate negative $0.15 EPS impact in fiscal year 2024.
About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized. For more information, visit https://thenext.jnjmedtech.com/.

About Biosense Webster
Biosense Webster is the global leader in the science and technology behind the diagnosis and treatment of cardiac arrhythmias. Part of Johnson & Johnson MedTech, the specialized medical-technology company is headquartered in Irvine, California, and works across the world to advance the tools and solutions that help electrophysiologists identify, treat, and deliver care. Learn more at www.biosensewebster.com and connect on LinkedIn and Twitter.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding the acquisition of Laminar, Inc. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the MedTech entities and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: the potential that the expected benefits and opportunities of the acquisition may not be realized or may take longer to realize than expected; challenges inherent in product research and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new products; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; economic conditions, including currency exchange and interest rate fluctuations; the risks associated with global operations; competition, including technological advances, new products and patents attained by competitors; challenges to patents; changes to applicable laws and regulations, including tax laws and global health care reforms; adverse litigation or government action; changes in behavior and spending patterns or financial distress of purchasers of health care services and products; and trends toward health care cost containment. In

medtech.jpg
Exhibit 99.1

addition, there will be risks and uncertainties related to the ability of the Johnson & Johnson family of companies to successfully integrate the products and employees/operations and clinical work of Laminar, Inc., as well as the ability to ensure continued performance or market growth of Laminar, Inc.’s products. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 1, 2023, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q, and other filings by Johnson & Johnson with the SEC. Copies of these filings are available online at www.sec.gov, at www.jnj.com or on request from Johnson & Johnson. Neither Johnson & Johnson nor any of the Johnson & Johnson MedTech entities undertakes to update any forward-looking statement as a result of new information or future events or developments, except as required by law.
Non-GAAP Financial Measures
This press release includes Adjusted EPS, which represents a non-GAAP financial measure. The Company believes that providing this non-GAAP financial measure enhances the Company’s and investors’ understanding of our financial performance. Non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. The Company’s definitions of its non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. The most directly comparable GAAP measure to Adjusted EPS is earnings per share, or EPS. The Company is not providing a reconciliation of Adjusted EPS to EPS, however, because Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis as the Company is unable to predict with reasonable certainty the ultimate outcome of adjusted items, such as legal proceedings, unusual gains and losses, acquisition-related expenses, and purchase accounting fair value adjustments without unreasonable effort. These items are uncertain, depend on various factors, and could be material to Johnson & Johnson's results computed in accordance with GAAP.
Johnson & Johnson:
Press Contact
Tesia Williams
Twilli65@its.jnj.com

Investor Contact
Jessica Moore
Jmoore29@its.jnj.com

 EX-101.SCH 3 jnj-20231130.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 jnj-20231130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 jnj-20231130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Information [Line Items] Entity Information [Line Items] Document Period End Date Document Period End Date Common Stock, Par Value $1.00 Common Stock [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code 1.650% Notes Due May 2035 1.650% Notes Due 2035 [Member] 1.650% Notes Due 2035 [Member] Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 1.150% Notes Due November 2028 1.150% Notes Due 2028 [Member] 1.150% Notes Due 2028 [Member] Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type 5.50% Notes Due November 2024 5.50% Notes Due 2024 [Member] 5.50% Notes Due 2024 [Member] Amendment Flag Amendment Flag Class of Stock [Axis] Class of Stock [Axis] Entity File Number Entity File Number Entities [Table] Entities [Table] Entity Tax Identification Number Entity Tax Identification Number 0.650% Notes Due May 2024 0.650% Notes Due 2024 [Member] 0.650% Notes Due 2024 [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 6 jnj-20231130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 image_0a.jpg begin 644 image_0a.jpg MB5!.1PT*&@H -24A$4@ #P@ '" 8 "FH?B8 "7!(67, $SE M !,Y0%USO"5 J4E$051XG.W.(0X , P#L?S_TQL@KM=FV:VT[P !)14Y$KD)@@@$! end GRAPHIC 8 medtech.jpg begin 644 medtech.jpg MB5!.1PT*&@H -24A$4@ E@ !X" 8 N58S# 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

[9T'F"5%U?Y+/\.G'PKLSNT[NR0#(A(4T0_,"BKF@(I\)A3$B 0#B!DQ M@(E@(*B @HHBR0 F$! %R:PN+*S LLON[$Z>S7GV_WMK3L^_IV]WW]LW[.ZP M]3[/>>Y,=X53ITZ=>KNZN]H%! 0$;"Y8UN6F#5;=Z_HK[KB^JKN@O^K^UA>Y M6;V1NQ>9W1^YVY$KAKK=-TCSGJ&*>]9%SOV790\(" C8LM _U3V!(/F]D:J[ MA.!X498LK;I+>RON4,LR*<&$<-0*VI'5/@GG+F/"V-^2!P0$@%NGN<[= MQ("XEP%$_\>B_Y/GAI'EY%FG?)$;A'A\:W?MBR3$O3?+^K-!_3WL98\(" @#PNFN2X(UGVZ M\HR#8U(4*#6P(%BG6Y9)"=KX,UU99[51HJMRTKS?D@<$;+&XU;E'#T3N&TNZ MW:C&?I(X2;1:I8E6Y(DTXZM7^E_']7\RO42K7>L88T-5]Z<'N]PTJVI28?X3 MW%0(5H_:G&Y?+!9COF99)B5HXSGJ]W3;)/(%]3/^<;0E#P@(R$,@6&,2"%9 M@',;G/LO)MCS-!ZRB))B 21I:5_D+B(F?(1C^_=/<\]96'7[Z=82>2\:C-PR MW4),YU4L&:52;ZN]W_DO\?>9.T2-:BR)UKR2<- L$*!"L@H!0"P1J3 M0+ "MG0,5=R+AJMN[>*,\:$8P*1Z+7%@*TM>",65P:J[;45&7-&S61"UT;XN M]Q)+/BD0"%8@6 $!I1 (UI@$@A6PA>,1C/$_K\V( [I5""%:LBAR>UK:AM # M@1)A2Z^&,MY+(LW]Q%_'F])-WL$@A4(5D! *02"-2:!8 5LR6 , MG*BW_#3>TV-#>UKU-3FADO^K&EOI,O76(1/YT.(N]S1+NMDC$*Q L ("2B$0 MK#$)!"M@2\4&YQ[!I/K[-1GC0^-?6R\,5-Q;+'DI0,P^H!4L[9.5+->_H1BY MY<-=[MF6=+-'(%B!8 4$E$(@6&,2"%; E@K&]E80H;NR8H G6(P-)M0#+7DI M4/8AV@,K3;!L!6N0\T^UI)L] L$*!"L@H!0"P1J30+ "ME0L&8L!BSSIR1@; M&C>]57>D)2\%)NL/*7XHCB3+U"0-J;M[]L[NL99TLT<@6(%@!0240B!88Q(( M5L"6BJ55%S&I]N41+(W_ODIS#[F3O^89+,;9AO5C=9UBR28% L$*!"L@H!0" MP1J30+ "ME0,[^2VZ8O<'-W*RQH;>EYJN.H6]T]SNUJ6AL%D?65RLA:Y4JP9 MI+SY4]W3+=FD0"!8@6 %!)3"IB)8LZ:Z)PQTN]VTV6!?MWLM@_I-_/T:ZGF1 M OGH]NYQEK0M: ?!6A2YIZ#?"]'3Z\O?!VC7:HY7+\7MZK;OV^:VULVLV2;#4:V=MMBK[V9P%XA??')US,^7M(_ MW3U=WPBT9&W%K<]QCZ:>OV=MIQ"+WB3LK[A?6):&,-3M=J+<)R17L;'Z'J7M] M_*%8[2#-E?0Z9(CS]U#W903ICRJX6!%-@WJ:(EA#%?P9%;N50U?'2+.'%=-VZ'FBWF[W-FSZ0^J]@]^%Z+5*FUW& M>LFG.;<_R MT3>'8)??H.?]TBVVHU:5\,M1RARDC)F,G^]3QHLM:]M '6>E;^4E);8?>K[7 MLM1%;]5]V;^!2%[*]P^VZW_:<9(EF538F 0+.^\U'+F/4]]8K(S&8J7J'A_? MU;%8B7WOX6_YSA'MB)74U13!4JQ$YZ]S[E;%2G1;%^NKN,3_JX@):+: M8EE;!GVI6'DX>OE8B6@>F1"3DK$2/6:AS^78[$@(3JG-?FCB3S62W9)ZQ7WFVRC[0F4#AO/)!!^8M[V M;HH56PKZU(QV*%^'Q'V7%/4C _^>9'#"Y_X/?>Z2OA*-0ZWX)/65#34FU![U M([JO1R[NGUK^EET>T.-@U:WZLL:'9"E"O2/XU[Z6+1?SN]PNE#7@[4H^M9^) M:PU^^QE+,NFP,0@6_OM:?%"Q'\L1#7J59L*6B53.75B95]ZC_+XF,4 M1&]BK,S0-XZ5-AXDE]*/+5]X-(5.$BPF@*?3N$O4(7%CT^6K0]5YJE^_,E Z MC0SF"0)7&73V.?.FN.VLBH9!&^L3+*XRE%:=@:XS]%%:U9V5/D_4#@T, M O M&UVZ5[#R02NC/(F<"=9^N=(R^3].9:N.O#[+$UWUJDW8^(ZRDS.._DCL\[DE M#'AM2*D^39:M?I,^&C22.)#(Z9/I)!JP\@?U)Y/)]W6[V*HI#9%-]/HX?K10 M>DF'M!VE@_I1YR2J/RN-'Y0(;;D;?W^;5=$P:,OSXT&>+#L6E4_PORU>OB;( MG+R,XQI?>7V?)1HS\E?(+;_5F%?[L,GM3!+CWQY4?8RSG;2<+U^TVR;_8Z.@4P<(I#V: ]ZIQ64;T@02A[O7( M N1^9*$Z3\>SB$T\L>!H#Z#/ 5950Z#L0H*EP42:@[4$B;[WR@'C;-$=M MN\$& ME^CUC!7UGI\.%MC+UZD)@?]'&1!ST/-VY#;^_Q>R*!X4L;Y)44#V1*'JKF]F M(K@_RG0W6(?1Z )G#^:7224$B;7/]KZ 'D93.IY9Y[JD1 M@H4>-RLMOU_0V) -I&NZ'QL)(M*3NI;2-\_W"K0(@MA7I%.]NBVPW@XIF&99 MQZ$+@'A24]N0^4,5]QW(U$L@A RU2F"A4T.HL\7-1 K1Y'Y'+L?Z5$_%<9*CO/[X(*2L9(VUB58].'AY9AK9U M.])1+\> I_"[.&^0^PFPVRWE*OK_K,JZH(V%!,L"V&'4^V,%)ND9LW3.*[ M MD<@A5$[1E;Y$3J!T..DQID(NZA$LV8$@? %]\#&5J;)5O_Z6HY%F*;HM1M9+ MW[S!D!0C@+\V%0I!NF^)""4' W7%5]%KT.<,+6$GEXL5X/"#)Y'N[9S_D]H7 M#Y"D'M+3EO6O:_0J5M R-X'O%D^X4V6J#OFSZN/<9=CM;:3?=61[-T7^SO][ MT2^'4_<-\J4LO31PK>Q+&IWL&R%8M//:0:[X*%^KL;YN]9GT1:<5I!LAS6KI ME1=L8Y'.WC_UO $7!J9&T\ NW9"LGJQQFQ;OAWKV+W%%C9UVIT^NUB0B^_'W M,G3\#?K]GCQ#*E=C7Z*_-0'%-E"PC,>;^>_MZ+/QKS@+T F"A;T_IECI?2-5 MEL:&;,7?BY"O0FA?$L=*3?@.*E8SA=UB5=4$;"PF6QCW] M>A3^>EXR5EK;=:Y\K%29D?NXJ9 +=&N$8)V!'*V_5796K.1W79E8B2\VM$T) M]7Y#Z=.Q4CZC6(FJLO33[5':_2SJ/0SQ+\%DZ96(E9E>;UD*09Y"@J7.H;,>(."-2G<- M//Z_F0[^).?WYW=/Y)D0B=>0YFN<>T@[7*?+28I-5 LU<9D:F:A'L,P)=;6_ M6+I9O?/(=Q*_;Z#\O=!_=_Y^&6F.XO@MTC_/>24ZIU4:\A9.8EPM[;=8MQO& MVC(NWN''7E*H:_\O.?=(\ARG@2A)EB-1NQ6H95?+4@CZH:J D;QRCB7V#>H9 M)$WAI,+ET6.QU>?\U9#E398EO10L&VC/5/5?]2*![P4#%O9>T5ZB_E3:M6RS247Y-.9\V-5H"NGT@GIBR MZHM%]QUYH:F:#< M_8:[W?J<6*D+IS=:TESHPE3/\#+^1HT03A"U6^,)FS;TH@@Z1;3QEKQ8*;O3 M]D%T>Y=ER83> J?NSY!V5+$R79;BA4@6>EV\H8$W^,A32+!4'N='D$7R,?41 M?R\E_=G$RK?U=[OGZH4.Q5SZ\;WT[^_KQ4J)CUFTP]3H/-I)L!94W(LP_G*5 ME=5(,4C*N[S1I<2[I[NI&.[FO,"A@4U']/=,<<^P++D@?2'!4GGJ( TD.G$] MQXXO>EU65QRD^5.]0.3K)/!8MDS0QD*")=TTR&-'(]WY1;?4Z-/'D^9;ZH>B MB5+]0=F_L6R98 *]PM*-YU.9TK>G@2O.),A[@I\T$F7%X@,8!!(_*_QT"@'H M40R0W]B57(WX049PG1^Y5UB6NB H'&W]7E.>VJI;-P2JNI-F/8(E&^J<#_P( M_7ZM)B/+G@E-*/3]ZG303HK& >7<"QEN^EFV&-CWD>AY659 3HOZT>L%892O M2=0VC5?93#[+N16( G@_=AX@GX*D#W3U?-Z7QUBD;35OA6T*M)-@X>Z)I/U7U@"7^& :N3EBU):E(9!^=PP]+$.GRU0]GI%&[NJ9 MSCW&LF2"M(4$2R('T4"CK0U=->NV#$'K;K4MJSR)MQW.H0%HV6J 70H)5BRR M+;\_L6QU0=I?6)Y,T0!C( _AE)FKB8N[W-.TPI)V6/4%^0;+]J5=!=V192^U M?8."6.2^8,DSP?FC-?ED!4.5H:#$0*Q[6S8-\OQ$Y:;+E(A$8(.UI"DD;?4( M5BR>7%7=#8TN5>N**R_82E2G^K*>?HU"SWC@DP](SZRQG!3I)'^0#N190__T M<>PRSAV//F]F+#U+$YR>E^/_JG^H?6R/G:^2_M_QRE96/3IFMOI/^I;*ID"[ M")8>5*9M,_)BI<7B>;*796D(C,<]\+VA+/U4C[\-U^VNF;E;<:QLA& E8F5# M^YGIS5SZ>V91K-3*/+'R.EU$6;8:U"-8L?@TD3O?LM4%8^QG17DI?Q2U/KSI9K.Q?7D#RLB#"2O[;-3Z2Y4G4=JUBT;XO6O),T*8C M98>\6*D^A@P57OQG@?;4BY7K\8O"Y_Y(6TBP8O$7!MWNID;?[(8 ?KHH5JH^ MZ8A^+[ LG46["!8#]TMY#\BJ@^4H!("F=DJG[A/S.E1E^T!E;P#F@3;6)5BZ M@F*@7&)9&@*ZO4]!(\N))7Z 5=T(D\SVEJ4&#)2Z!$O]P_G_Z,%2RU87"Z:Z M7=%KJ5])R!#5YYVQXMYB628 QSYHI09R*I_WE&EC;]>'8.V'F-O#OER M%9#4?Q)TT0L/9UK2&BB(D7\@SU?E8YR_3;?^+$O#P#>?1)L&\R8GZ4?POU57 MO):E!HT0++5W1,\F=;F]+5M=:$42W>[."K:Q^ FQXDZP+"U#MRD)E,.>A&?4 MEQ;Y+V/P^C)$")O_#S[V$;T-*3_,JT?^PF3Q,]Z3LJR3 !V?ZOJ3<\# M:B]^?:?&L"5M&/C ,3%9D,2Q4G,AY:Y7/UG2&N@-76*A7UE.ZA.+C;<[ZI'M M+-A^?_VVDE8CTE%E%\5*TM4E6&KOD)ZUFNZ>;=GJ0A?QQ.E9143>;F66O@AO M"NT@6 ]!'E!X0%6O :-$"P%'XA0J1W1!=KW+9\W MHTR)=,/'2TUX]8"]W\B86YY'T).B-A,05W!%7#AY9V$!9)/Q_4 >R?)MB_0R MZZ9%.PB6)B?:TI\7*VUB^$^SMWNU6DCY@WE$06..W_^0+OB,+?ZI2]OP\^VD,RRX0[_TL2PW(7TBP=%SGT>UXR](PL-L?Y8-YY5K? MGFC))X"X]BG9-JV7VD.YJXUJ4LLBE%^K'4U_VDXRCDM;]%#-I#_%"VHD*XNP=*\13SW6VZ4 ?;Y>MX% MC,3BS 66O+-H!\&B09\O:I#.J=&6O"DPH5^8-\'$.C+YO<^2UX V%A(L"VRW MZQD4R](P:-LU>0-3SBS;#G3G[X!=CV")R7-N*0Z[NV5I&.3_6E&[+9#^T))/ M@%9$LLB93::C^,1;+6G#($\W??E/ L?%!(D/\O_.1;=/8SPT-C'EDGA_G."- MC4K=MDQ"G_:@O];G#7H_#M =?3,?>*]'L-2_=K%1^IDBK2:JC7D^(MVPSS\M M>*Z9AB'A#Y/R#R>FR;9+J;:5OVX&V M$*RJ^TR\@ILEBG'8\MN6O"E01VZLD_]X7ZFZPRQY#6AC(<&R"]K;ZCV6D07= MHBR*XSX.%ES$U"-8BI7\KFIF1WL?[PK:[2_N(O=C2SX!Q/#/9A$LQ0-M8["P MX@ZRI U#A%1C>BAREXP0*R%$3]-S578Z%Q9CALW^"IU'K2\3)OOR1L+\F7:K!<@,C^_4(]@&5%>,E+G0?XL$&R? M+_*2%S0T_C0.BQXV;@2W3G./7]3MOD0;EFBRD;T5D.6#>77'@H]Z,J25+,C0 MZZS(AD&>$[/ZV).NL=NJ#=\JZ 1:)5B*E?CQC**+,2.8^UN6IB""(A_.ZR^- M>7SE:DM> ]I82+#L@OE<2UX*Y,]]+E3]KKA"V;FW;]"MD&"IW>2_FSA3GOQ% M[@-%"P6>?'6/[4>8!N>/SR)8$HT)XL9]^'>I"V1=R#6S_0HZ?J3(1K[_6XR5 MNAL%@;JK:-[7RC>$>GQSX21(4TBP- XH?W%_$Q^$5YV4O4[U9Y7M+P*)\Y:\ MLVB58.FJGS2YAE(PHOQ%S2R1)D&PV ,BLLRN4&I$QTFS5"S?LDP .A02+)V# MH#7U^B:==4[1\PW BHXX]%@=E/6DW<0DV#LLXO6F'P]^^[W3J8"1EX_RG_HQ[O+["66AM[&Y4KY&O6YC=NQ8%QU_Z+L'ROHY06M M6)1'?D&Z06)&J5M(>KB>?AXPDC$N"H@<7TG?U/U$3R?1*L$22:;_<@._MWGD M>EO]"+F>)T)/_ZV]K'ID7^I9EG=Q1-Y<@J6QIG/$K,];\E* _)U55+9\![_) MW7($W0H)EH\#D;O2DI<"^=Y=CV#AW^.?X4D">QZ>%\,U)J07YWKP@0]K,VO+ MUA'0CM\5K<3Y-C;Q<'L:NGV7UY<2T^%42SX!'"\D6+9J/7>TB0V'\9\7TKXU M>?YO=?98\LZB58*E@::@DN?P&C"4_W=+WC3T3()8IYPXJQ[5[YTXYS8A.A02 M+%O^_: E+P4R9SPI#$/:..?W82*@GJ8QE->^6,;S M5MW\AR"&OH(&01V7I8.V$:SE(]/<G)EQMX_&9M[XU)A0C+(8H%CY ]KY5KV(9$6T!?BFG@FNN4B) M16.7<:F-LQO:$ZT(Q)M/J"_S^D+G2'-SUFHBYPL)EEV,WI<59^L!N[X(&^<2 M+-]'D>NWY)U%JP2+-)<4!0TY/!V>^[9#&=!95^<-3HGT8'"=;NJZ4]1TL*[8T*.<5"DYY]O&KFDS _=/++R>GH:"G\O(&OK_ZK[K% MC)N:U[4G*\'2/CB4[;^<0-M\>7J>BG8L[NEVS[5D8WMDV6= \OHB*?+;(?P' MG0HW%4Z"\C^;?I'!",T Y>2^7;8QT"K!PK:_*8I?LBMIVO+P+7I>4527?[F% M"R)+/@'DK4^PB%F6O!0V"L$JL3U#$JT0+'3>2N.OB5@YS/$;R/M];3:L6V+- MD(H8Z'% 40PRXK646%6XIU0CP']>I_;F]44<*]&I9K\NSC="L.YOYF*#^AHA M6'V6O+-HA6 IF.,8,_/R2A1PR)OYYD598)2?% 4-&US7T"DU#TW3QD8(5E-O M55#GPY)@";3ML]I^(RMOEJ@-&ECJ)XD-0&TN>2-M.',XK6@%!/08'9A6N\_+9"18?=/WN9K8%:2=:(5AZ M?E)MR)N U5Y_@=C )HV-@#']XWHKL;3E.DL^ 1R?W 2KTAQ);85@"9P[OBA_ M6M2&=*RD_Y=P_ ;L>\9PQ;VE;*PD__C6#EEUVDI_3_*S9LV"BZ__I9[A%;!\-?,M]DDLJ,%PII]BB8; MP=(W[')\85Y>C1/9?;#.5Q\:!?WCOXF759BF" M-@:"E2'U"):>K216WBL=TGD;D9Q8.4^QLJ>KL=OCE'-*>@4X*49<_J,/^%N6 MIL%XWE7S?UZLC/LS*U9R?K,B6(\@2&S'B=?AV">AU!]),+!!AHS15P^,W=/J$,Z*C/%[%S!2_T6;!\N]I-/3D>"%:&U"-8PJ*I M[N4CD5LI';%19CF-BMJHX*Y AM]H#ZQ3(!R%#WUCWXN*"):1[G^T*6CX!ZV+ M)E&[:*AY(6*R$2S2GYP.QK&_\G?AJC/U1*2YO1&2I3+]V*,?ZWVG#)W>(3O% M8R'6A_'3\.U[]>%@EWL-]7U]*')7,K[Z%"OQW::>S8G1"L'JG>[VXOC2O)51 M]:N1GJ8V&$V#"%:&U"-8 KZWW^+(+??$ M(J.,,J(VQK$2OUD^'+GOSGMBG5BIEW0*VJ"^PX9W6/*6H$\@%8T'Z>_G:WS1 MLHR#\YN>8 U6W*L5!%'B+_P.B2FJD[6EO_[VMVZBQC^=DH56"):_G5)@I'C MD.;_+$M+P 8?3P;?M(C]DV9D?I?;Q;*, QT"PDE2<3*IK86B-$*P2)6/@^]I MNG_-K[B]K*H:,'XNEPVRRI#X^3AJ_:4S07>P*&NN'Z,9=:GM1K!.MBSCX/RF M)U@: -J-50:3@74BV6&^PR-WGI7;%%HA6!Q[89&1E+>M!(O@6X]@88^E61]_ M)F\@6!G2*,$2&-@O&.YV-ZFMZH>\,LN*KK29[.?H]7*K:@)HP^\:(%B%WWML M%"(HE-63%S0DMNKS']0?DW C<&Y[\5C2>5)1\C)3^UT)M1FW9K9,+UNK&SI99M6"%9?MWLI M[:IEZT20.R<+S:G!=3C& -,TG6;&LC.Q61H$"PZD.+#\Q'-\A_ MVQTKAR(WKS]G?RC&P96R059>B71AC.7N@58&C1(LTM0\5\CYS8-@%76,!8U- M1K VP0K6)U1>WN R@C4<5K#^/[!'VPB6('* GD=QA39#05H!267HRKR5(*)R ML/\-^&/-YY2D7UY0EMBYMJQ@,5E'&GP-K&!]Q;*,8[(0+#U7AQX/*$^Z'&_+ MR%U;YJW/AZIN7_J_W\9Z39E)41OD+^A9\RD3$63Z^A9O)TM+N:L9'\^S))E0 MFVG[K#A?EFQJ@H6.^Y)W55C!VC((EJ#GVYB3/DJLO$/]KK+5=LU3;8B5-V;M M>*.X#^7V*!L:;1BGLUY9]"C+@.NR_UL9+R?*Q$FHF5E%/3 M!XR;GQ:UP<<)+H[;L=H_M(W;B?XH?''#"%;-MVXYO^D)%A/?W"+RLC$)%DJ? M8EG&P;%N.GDX+VA(C+CDDHLRH)QOV62:*3:!_9M)LN9M)?(&@I4AS1*L)&YU M[M%,JCM>_9)5CC^>L_%L/5#WVYDX M5A41$ GV]=]G@X2O6=C]_[_1AO[?B,>H[$][5PPW\*8IMO%[$,D&Z;IBV:@$ M*^.[J[KHXWSNK6>-??D'_7NL96D)V..;16\1^@DL<@]LV"UC$\A L#*E68*5 MA%[$T;.+VH*!^KY#S/@K_3#23*PD;L],K_C3]F_7ZW=^15P*7S9I!,RSNZ)[ M_;<(,VY[#WW*Z?D[4Q<;;/J( M] NL* \"T4<5>/+L8U?C>BZAYHVHLJ#N%U+6FKQ;.:;C>MI1LVO\9"%8V#-W M I4_\/OW9C[D*RR*W =T=9X7=&.1#TAGTBU1?^O[E-AF?+=^K7Q35D-[0NG- M1/+V;J",I%BLS/]3;*$JL8-6\@2D=Z9^9>3K*MZ6C)DC+TA(4DXK(@EW, M_-623P!M# 0K0RS&MT2PTM#'FVTEZ$W4?PJQX^_TRSJ]R%8O5NH\MIKP.2K^ M/U(VS+./$7RM.C7]H><8U+$/4OB(D.HC)M5\NY7SF\$MPJJ[H6@P6]!HZ7:=+.:X,&$C9LZ@OZ M:1"<]090+DD2<4#WD7E3W':691R3AF!%^2\->+):<8L@-PUM#)H%=/ ?OLT+ M<+'(!Y1.\0>=_A"O[EC,N//^C/WL\D"^&_+:)+%8V=+%J @6NBXHBLD^CD3N M$Y9E JC_DB(=_>3>XK8[ I/2(]#A#T5U^5M,W>[[EF4"T"$0K SI!,%*0RM< M_=WN?XDA9Q?%2HG:FHZ5C+W]99N\&.1OOT=N^?PV?#B=\MZ@_LKK"W^1%;DA MVE'S)0?.;Q:W""_T03F5(!;O3! '*[TR'B^L9%[AV69 )RR M\&%*"Z#_M.1-0[=_L,>]&MQ9]:A^;ZO(O=.R3(#L% A6K6P,@I4$$_>;&%2+ M16*R]-'R]J*J^Y8E]]##E.A8>'O%^VB7>ZUE:1H$K$_7N_+G]Q^:Q"S+."81 MPK/1VK$Q\FWGQ='\1D.NC&H\V MOM]L69H&=7]*.N3UA<[ASS<2*VO\F?.; <&JNL]HXL]*)+%@_Q1=7F&\E?$D>NGT2U]Q@1G>R8!:GG>+5,=1X\EI*MY M*T:@LP+!RI R!$M$A^#].OSR1.V.;8=+ SOG;K=A_5#S/4G:D?N%>)7C)Z>, M#>W*0GY2- G:>,R\Y3U9"!;I+LZ;Y"1^DLI9"2X#RCA#8RY/Y[3(;A LD:O2 M#WHSAK[10)LR;XDU"O\?7XF)SSC3B!O(%@94@9@J7YKJ][;+/;K-7N1M'3[3XJ M>V>-(4]@*NY,2SH.CA6^2>AC;.0^;\F;!O/ +XK&G'3 3[YIR2> \YO!,UA5 M]WHY7%Z \LN'D7M@M(F '<,FA=SO"5D=\PEZF;<,=/L'0]]F9*]&I#L!:92_ M6_JD#P3CO44#2\_WB"C0(9D?RM3$&0A6K101K#G._3?^L2>^<22#]G+TG*OT M\DG\X966K#2TF:=\*FM%2BM8]$/-1V@A=^_78"ZR$>VXTI(W!1$?RIJ=MU)F M!&<= WC",V(Q)@O!(OUI18%1[?V6%*MW+O9I: ^N M)/"9@^6;>?5H#. ?]\S9R6UC64J#LO>EGN)8B=WH@\BR3("NY-'AECS;JV]5 M!OE;C96'YDW*$HT5?O]@R6N CP:"E2%%!&NVH? M99[(7(DFS:8G6/K>( 9]EIA))="7%^54TXIE6=FG0>8<6.:R("[]7T-#< MUSI1]I-%KP3;+LK?L^1-@7;^NM[ I$-R]]OB7"!8&9)%L(:W=MO@4]]:7'4W MDW^MTJA]"OXJ1W:DS1^WY$V!_#=E]:?WE8P]ID3P.;Y0;4FFCT5C!/L-Z T= MRU(:E/,R!GSNH%<_H,?U>C#5LDS 9"%8\O.B,2]1?Q,;:MX<+@O_(@S$U_JU MKJA_&0^_*VLC"/@NV&9)W@JW!?S5LJ-E*0WL>WB]L<3OGRQY)BCC&-FV:*PS MT1?N=E\/V/N7>;%.NGL])/S>A6TVLU/^#%?+2:)"=-ZZ4W M7&CS;RUY4Z#\&]-^)QWE*PR0S&=#\-6O%4W4/K@V&?@%RC^[WL1$8#G8DM=@ MLA LTNQ!.2N*WE#6Q1L$>R7U'F#9FH:NPFGW]5F31%KD:[;B=0'!-9/(9D$/ M!^/'U_K GBHS+E?GB%69#Z W ORC,(;8A4>A_\T9V]IF@?HKJPSY/[9Z2*N\ MEJ44[/MPPWG/[7@?CMR_17PM2PW('PA6AF01++T!B#U7;""?QGU:+^F#7S:] MLBZ"A5Y_2=LL]N>!;G>()9T TGPU+U;&>=&[Z8MD\OX@;\Y3C+)8E_DLHD"Z MS8-@8=R/%'W3R ;,+7E,L0@$6A&7@3SB8LN2PT7? 8M!HXY5@,G2,^Y0 E3- M[LV-@*!X,[N)_;!HR\[8*'-/ M%W3RP14_+-R^8+(0+,4*^OPZ^55661*U6?K2EIZB;Y\U"NE%N7?G780E16TT MLI+YEEL>L&WAY.LG[ZJ[;6;&WD_UL&);MP/C=#"/N-AS32.TL^:-J31HUR>* M5OS5!LJI^9AX(\!'3[*[#C4BNVI,D^;=ECP3V#$0K S)(E@:2_1[S<5B+#Y6 M1FY9__3L3]O4 [;0'F__\<0[62[_TY\K\),]+.D$D*^;>CV1UUA.YI7X&!JY M>YN)E?)QRLY=\)#_46?ARQJDVSP(UORQMP+F>H.D$DH23GF$SU "!)L?%059 M3SH:#'*Z(B*M_TY=5HZ!0( M5H9D$2R!-GU1W\',RB.13@3JIF[[VJ[?-BOF1P^V>Q\@:F]")- MZ7W7L,&O\OI0OJO5G,&<9Z]B3!:")6B2E1WSRI-H',L_F"3F4?^K+&MI4%<5 M'_\X^C]4M&J6%-E0^BW,V'\O#[:7UIQZL1(;U7PMH!Z(E6<5Q4JM%F"OAEX, MV#"V?^ -GD1FE"5_HU\&\K[-F0=BY;.Q<>[&CSY61OYQC\)8B0T#P29(NWD0+ $C?%@&S0N&:A1!<''OM,:7\^DX?4\NU_C^2C-R M_:2K>T460P,R&7 /(;V7I<.LO)#"ZYOM:2Y(,T% MZJ\L>YE>:Q@SN-D_RT;22WU+.^NNODXF@J7OI#$1W:"V98W56'1. M>E/O.B:@4]"A[EB+,12Y9U+&U^CO!W55&Y,K^9Q_#B113Y:HO:J;OFSX5@8V M.%SC):\/C"PO[NUVK[8L=:$Q)'T+8R6$2+>++$M=6'\.9L5*_>_'1^3^>5_. M _-IS!W[Q-.=RI=5GFS.^?F-/'=#ND"P,L1B? W!&IKF=L3&@WFQ$H+D8]*" MR!UH61J"7C*BG=?ZODN4%\?*GHI[FR7-!>/A)WK4HR!6KF7>;OA;P>H;BP4+6L-%" Q M^G>U=(EQ:P:C1.?4J03KTM\0Y(KSH"4XDQFHIFPY*3I<7^^V@S9;(]V=&C#I M,B0^2%?=, 'CI9:E$.@2"%:&R(Y9!$L@X'Q*5V99@R#V.?I@D++?;ED*H=>5 MT>=7"K#IMBH(X#N7,J#J?B-+;X*1_V]9@2/6"]]9S;FC]&R.9:N!-K*D[TY6 M>OE\LAR)VBV_8,#^R+(48C(1+($R7T"[5^9-#+'(I@K&?BP2F&C?V03E@]%E M#^V[TS_5/4&_NK7+N=>CQ^?PZ6LYOUS^H_+53_J5#2CO'Z3IRR(7:1&QH=VC M^,;[3.U"*" SP5Y>%"LU'HB5R^3?K-0Y(S6E8P2/]5#=6DNZVK%BIPT6_Q];K/*.IQ#"YTKLZ[(/4K3MJDNK)1>B[K\9KYU8SAY-A^")?3OX*9S8D:> Z@3%8PT8?+W M?CXW(4 O6I5G5IP*P/61*Y97D# MR1_G/!U^%K]OU [<&.6IU+D'?[\5ASB'XRO3S#T6(VD#,.576)5U05L#PX@)MNGD\=_Y5W/NC 13V.B>BG'OHPN<_12 M1KJ=?O#K&Y+XN*^X 5BYURAO6C?II;$@FT)ZKF,"^C!U[HL..\_O"SX^(')#_QT6!)XG)1K $TA^AO+)75KEI44".21-V6L*Q'NI] MR/]6W8C:KA@EOXH#L8\I'!N)7"_]?(R>8Z/_7D-9R_+(12PZI[KH#^V/]493 MNQ#R#?J[;JPTLJ=8>3;'%2O?I5C)W\?R]Z^0OGJQ4K;HK;K3K.K2H$WOEAWR M8J7L2%N6#E74/E;B!WM@RP/QN7/Y+8R5](/>KFUX$U[:'0A6AA01 M+/_<:M7])"L>2>0_/E8B]-UEBI7XZ2ZZ.%%^;7BI4/IF.E_I9^ MV'ZF=ACP%3< O3!!G5<5Q4K9'5^Z'A_[,/(\Q4KT>9IB)7\?2]TSLF*E9#Q6 M5MU/9^\\\3NR>2#?YD6P!$T.D(];\R8\B3I!RLG19% 9)?FW F16/HGR*0T! M\[N:7*W:IK"@XEZ%KG-4;Q;C5:=J.5&_U#>"#�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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 30, 2023
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Nov. 30, 2023
Entity Registrant Name Johnson & Johnson
Entity Incorporation, State or Country Code NJ
Entity File Number 1-3215
Entity Tax Identification Number 22-1024240
Entity Address, Address Line One One Johnson & Johnson Plaza
Entity Address, City or Town New Brunswick
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08933
City Area Code 732
Local Phone Number 524-0400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000200406
Amendment Flag false
Common Stock, Par Value $1.00  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, Par Value $1.00
Trading Symbol JNJ
Security Exchange Name NYSE
0.650% Notes Due May 2024  
Entity Information [Line Items]  
Title of 12(b) Security 0.650% Notes Due May 2024
Trading Symbol JNJ24C
Security Exchange Name NYSE
5.50% Notes Due November 2024  
Entity Information [Line Items]  
Title of 12(b) Security 5.50% Notes Due November 2024
Trading Symbol JNJ24BP
Security Exchange Name NYSE
1.150% Notes Due November 2028  
Entity Information [Line Items]  
Title of 12(b) Security 1.150% Notes Due November 2028
Trading Symbol JNJ28
Security Exchange Name NYSE
1.650% Notes Due May 2035  
Entity Information [Line Items]  
Title of 12(b) Security 1.650% Notes Due May 2035
Trading Symbol JNJ35
Security Exchange Name NYSE

XML 10 jnj-20231130_htm.xml IDEA: XBRL DOCUMENT 0000200406 2023-11-30 2023-11-30 0000200406 us-gaap:CommonStockMember 2023-11-30 2023-11-30 0000200406 jnj:A0.650NotesDue2024Member 2023-11-30 2023-11-30 0000200406 jnj:A5.50NotesDue2024Member 2023-11-30 2023-11-30 0000200406 jnj:A1.150NotesDue2028Member 2023-11-30 2023-11-30 0000200406 jnj:A1.650NotesDue2035Member 2023-11-30 2023-11-30 0000200406 false 8-K 2023-11-30 Johnson & Johnson NJ 1-3215 22-1024240 One Johnson & Johnson Plaza New Brunswick NJ 08933 732 524-0400 false false false false false Common Stock, Par Value $1.00 JNJ NYSE 0.650% Notes Due May 2024 JNJ24C NYSE 5.50% Notes Due November 2024 JNJ24BP NYSE 1.150% Notes Due November 2028 JNJ28 NYSE 1.650% Notes Due May 2035 JNJ35 NYSE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" / M " 881 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " #2@WY7 M)!Z;HJT #X 0 &@ @ 'F$@ >&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'-02P$"% ,4 " #2@WY799!YDAD! #/ P $P M @ '+$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" ( 5%0 ! end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 6 22 1 false 5 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.jnj.com/role/Cover Cover Cover 1 false false All Reports Book All Reports jnj-20231130.htm jnj-20231130.xsd jnj-20231130_def.xml jnj-20231130_lab.xml jnj-20231130_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "jnj-20231130.htm": { "nsprefix": "jnj", "nsuri": "http://www.jnj.com/20231130", "dts": { "inline": { "local": [ "jnj-20231130.htm" ] }, "schema": { "local": [ "jnj-20231130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "jnj-20231130_def.xml" ] }, "labelLink": { "local": [ "jnj-20231130_lab.xml" ] }, "presentationLink": { "local": [ "jnj-20231130_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 4, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 6, "entityCount": 1, "segmentCount": 5, "elementCount": 32, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 34 }, "report": { "R1": { "role": "http://www.jnj.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "jnj-20231130.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "jnj-20231130.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, Par Value $1.00", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "jnj_A0.650NotesDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.jnj.com/20231130", "localname": "A0.650NotesDue2024Member", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "0.650% Notes Due May 2024", "label": "0.650% Notes Due 2024 [Member]", "documentation": "0.650% Notes Due 2024 [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "jnj_A5.50NotesDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.jnj.com/20231130", "localname": "A5.50NotesDue2024Member", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "5.50% Notes Due November 2024", "label": "5.50% Notes Due 2024 [Member]", "documentation": "5.50% Notes Due 2024 [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "jnj_A1.650NotesDue2035Member": { "xbrltype": "domainItemType", "nsuri": "http://www.jnj.com/20231130", "localname": "A1.650NotesDue2035Member", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.650% Notes Due May 2035", "label": "1.650% Notes Due 2035 [Member]", "documentation": "1.650% Notes Due 2035 [Member]" } } }, "auth_ref": [] }, "jnj_A1.150NotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.jnj.com/20231130", "localname": "A1.150NotesDue2028Member", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "1.150% Notes Due November 2028", "label": "1.150% Notes Due 2028 [Member]", "documentation": "1.150% Notes Due 2028 [Member]" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.jnj.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0000200406-23-000109-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000200406-23-000109-xbrl.zip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end